Thyrotoxicosis: Adjunctive cholestyramine therapy;Crise thyréotoxique adjonction de la colestyramine au traitement conventionnel

Presse Medicale

Volumn 39, Issue 11, 2010, Pages 1217-1220

  Kahina, Boussaïd ^a   Maiza, Jean Christophe ^a   Bennet, Antoine ^a   Caron, Philippe ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE;

ADJUVANT THERAPY; HUMAN; LETTER; THYROTOXICOSIS;

ADULT; ANION EXCHANGE RESINS; CHOLESTYRAMINE RESIN; FEMALE; HUMANS; THYROTOXICOSIS;

EID: 78349308572     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2010.05.021     Document Type: Letter

References (16)

1. Nayak B., Hodak S.P. Hyperthyroidism. Endocrinol Metabol Clin North Am 2007, 36:617-656.
2. Hillier A.P. Autoregulation of thyroxine secretion into bile. J Physiol 1972, 221:471-476.
3. Northcut R.C., Stiel J.N., Hollifield J.W., Stant Jr E.G. The influence of cholestyramine on thyroxine absorption. J Am Med Assoc 1969, 208:1857-1861.
4. Bergman F., Heedman P.A., Van der Linden W. Influence of cholestyramine on absorption and excretion of thyroxine in Syrian hamsters. Acta Endocrinol 1966, 53:256-263.
5. Sakaki T., Fujioka Y., Akagami T., Masai M., Shimizu H., Sakoda T., et al. Cardiac wall motion abnormalities observed in a patient with transient hyperthyroidism. Jpn Heart J 2004, 45:1071-1077.
6. Cooper D.S. Antithyroid drug. N Engl J Med 2005, 352:905-917.
7. DS Cooper. Treatment of thyrotoxicosis. The thyroid. A fundamental and clinical text. Werner and Ingbar's. Ed LE Braverman and RD Utiger, eighth ed., p. 691-715.
8. Martino E., Balzano S., Bartalena L., Loviselli A., Sica V., Petrini L., et al. Therapy of Graves' disease with sodium ipodate is associated with high recurrence rate of hyperthyroidism. J Endocrinol Invest 1991, 86:1853-1860.
9. Witztum J.L., Jacobs L.S., Schonfeld G. Thyroid hormone and thyrotropin levels in patients placed on colestipol. J Clin Endocrinol Metab 1978, 46:838-840.
10. Harmon S.M., Seifert C.F. Levothyroxine-cholestyramine interaction reemphasized (Letter). Ann Intern Med 1991, 115:658-659.
11. Solomon B.L., Wartofsky L., Burman K.D. Adjunctive cholestyramine therapy for thyrotoxicosis. Clin Endocrinol 1993, 38:39-43.
12. Mercado M., Mendoza-Zubieta V., Bautista-Osorio R., Espinoza de los Monteros A.L. Treatment of hyperthyroidism with a combination of methimazole and cholestyramine. J Clin Endocrinol Metab 1996, 81:3191-3193.
13. Tsai W.C., Pei D., Wang T.F., Wu D.A., Li J.C., Wei C.L., et al. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism. Clin Endocrinol 2005, 62:521-524.
14. Sebastian-Ochoa A., Quesada-Charneco M., Fernandez-Garcia D., Reyes-Garcia R., Rozas-Moreno P., Escobar-Jimenez F. Dramatic response to cholestyramine in a patient with Graves' Disease resistant to conventional therapy. Thyroid 2008, 18:1115-1117.
15. Kaykhaei M.A., Shams M., Sadegholvad A., Dabbaghmanesh M.H., Omrani G.R. Low doses of cholestyramine in the treatment of hyperthyroidism. Endocr 2008, 34:52-55.
16. Shakir K.M., Michaels R.D., Hays J.H., Potter B.B. The use of bile acid sequestrants to lower serum thyroid hormones in iatrogenic hyperthyroidism. Ann Intern Med 1993, 118:112-113.